Cresco Labs Finalizes Acquisition of Hope Heal Health

Cresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission, and has thus finalized the acquisition of Hope Heal Health Inc.

Currently, Hope Heal Health owns a facility and dispensary in Fall River Massachusetts, and is fully functioning as a cannabis cultivator and manufacturer. The company also holds several state licenses, including a retail license, manufacturing license, as well as a cultivation license. Hope Heal Health also has the ability to procure two additional retail licenses in Massachusetts

In addition, Hope Heal Health has also recently been granted a recreational cannabis license for its dispensary, meaning that following the acquisition, the company can still sell cannabis to medical-use patients, but will also be catering to adult-use customers through Cresco’s several cannabis brands.

Now that the acquisition is complete, Cresco plans to distribute its branded products in the Massachusetts adult-use cannabis market. The company owns several brands, including Remedi, Cresco, and Mindy’s Edibles.

Cresco Labs is a United States based cannabis operator, and is currently trading at $7.31 on the CSE.


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Related News

Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022

Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million....

Wednesday, May 18, 2022, 11:28:00 AM

Cresco Labs: Stifel Raises Price Target To $21.50 Following Bluma Acquisition

Yesterday morning, it was announced that Cresco Labs (CSE: CL) is entering Florida with its...

Friday, January 15, 2021, 11:53:00 AM

Canaccord Lowers Cresco Labs’ Price Target To $9.50

On May 18th, Cresco Labs (CSE: CL) reported its first quarter financial results. The company...

Saturday, May 21, 2022, 03:02:00 PM

Cresco Labs Insiders Unload $32.8 Million Worth Of Shares In Early Morning Trade

Yesterday morning, popular cannabis investor Todd Harrison commented on Twitter that unusual trading activity had...

Tuesday, December 8, 2020, 07:17:38 AM

Cresco Labs: Canaccord Drops Price Target To $16

On November 11th, Cresco Labs (CSE: CL) reported its third-quarter financial results. The company reported...

Saturday, November 13, 2021, 01:04:00 PM